The Fort Worth Press - RFK Jr panel votes against ingredient targeted by anti-vaxxers

USD -
AED 3.672499
AFN 66.498782
ALL 80.629676
AMD 365.091035
AOA 917.000408
ARS 1492.336499
AUD 1.414877
AWG 1.80125
AZN 1.701052
BAM 1.691649
BBD 2.00813
BDT 123.418242
BHD 0.375989
BIF 2985.079791
BMD 1
BND 1.277602
BOB 11.849673
BRL 5.083698
BSD 0.997016
BTN 94.875232
BWP 13.457596
BYN 2.968819
BYR 19600
BZD 2.00519
CAD 1.39518
CDF 2262.499098
CHF 0.808199
CLF 0.023198
CLP 912.999827
CNY 6.747602
CNH 6.743155
COP 3157.68
CRC 453.228387
CUC 1
CUP 26.5
CVE 95.372573
CZK 20.984797
DJF 177.546166
DKK 6.46806
DOP 58.20179
DZD 132.308956
EGP 49.569799
ERN 15
ETB 160.923669
EUR 0.86521
FJD 2.20855
FKP 0.74148
GBP 0.741195
GEL 2.610161
GGP 0.74148
GHS 11.700039
GIP 0.74148
GMD 73.496802
GNF 8756.649224
GTQ 7.607144
GYD 208.588851
HKD 7.845875
HNL 26.723176
HRK 6.519601
HTG 130.363707
HUF 314.212956
IDR 17801
ILS 2.99985
IMP 0.74148
INR 95.21055
IQD 1306.058902
IRR 1375550.000465
ISK 123.37984
JEP 0.74148
JMD 158.335856
JOD 0.708953
JPY 157.888997
KES 128.789741
KGS 87.449779
KHR 4049.647537
KMF 425.999543
KRW 1411.360366
KWD 0.30866
KYD 0.830861
KZT 467.275008
LAK 22510.919863
LBP 89282.792025
LKR 334.420274
LRD 179.959348
LSL 16.197552
LTL 2.95274
LVL 0.60489
LYD 6.341738
MAD 9.29222
MDL 17.337716
MGA 4254.638239
MKD 53.219738
MMK 2099.549369
MNT 3595.852714
MOP 8.056654
MRU 40.080439
MUR 46.795264
MVR 15.450064
MWK 1728.841413
MXN 17.138497
MYR 4.085099
MZN 63.904996
NAD 16.197552
NGN 1361.789707
NIO 36.690741
NOK 9.50157
NPR 151.800372
NZD 1.69811
OMR 0.382693
PAB 0.997016
PEN 3.376465
PGK 4.406003
PHP 60.814978
PKR 276.796523
PLN 3.719555
PYG 5928.296501
QAR 3.644596
RON 4.541503
RSD 101.492021
RUB 81.61994
RWF 1466.072741
SAR 3.744756
SBD 8.065696
SCR 14.449077
SDG 600.504962
SEK 9.48365
SGD 1.278665
SLE 24.60377
SOS 569.822255
SRD 37.866499
STD 20697.981008
STN 21.191022
SVC 8.723782
SZL 16.194265
THB 32.970555
TJS 9.197509
TMT 3.51
TND 2.929032
TRY 47.714698
TTD 6.757774
TWD 32.250104
TZS 2643.563029
UAH 44.653894
UGX 3714.050945
UYU 40.133201
UZS 11924.058297
VES 755.762399
VND 26204.5
VUV 118.557141
WST 2.733716
XAF 567.363231
XAG 0.015658
XAU 0.00023
XCD 2.70255
XCG 1.796912
XDR 0.705618
XOF 567.363231
XPF 103.152705
YER 238.395817
ZAR 16.14803
ZMK 9001.197294
ZMW 18.818492
ZWL 321.999592
  • CMSC

    0.0240

    21.744

    +0.11%

  • BCC

    2.3400

    86.6

    +2.7%

  • BCE

    -0.0200

    22.75

    -0.09%

  • JRI

    0.1500

    12.81

    +1.17%

  • RIO

    1.4500

    101.1

    +1.43%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • GSK

    0.7900

    52.96

    +1.49%

  • BTI

    0.6000

    59.33

    +1.01%

  • NGG

    0.4700

    80.88

    +0.58%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • RELX

    0.0485

    35.52

    +0.14%

  • BP

    -0.6000

    41.63

    -1.44%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • VOD

    0.1900

    16.19

    +1.17%

  • AZN

    1.4100

    161.42

    +0.87%

RFK Jr panel votes against ingredient targeted by anti-vaxxers
RFK Jr panel votes against ingredient targeted by anti-vaxxers / Photo: © GETTY IMAGES NORTH AMERICA/AFP

RFK Jr panel votes against ingredient targeted by anti-vaxxers

A newly appointed US medical panel voted Thursday to oppose the use of a vaccine ingredient long targeted by Health Secretary Robert F. Kennedy Jr. over debunked claims it causes autism.

Text size:

Thimerosal, a preservative that prevents bacterial and fungal contamination in multidose vials, has been extensively studied, with authorities including the World Health Organization finding no evidence of harm beyond minor injection-site reactions.

Though thimerosal is now rarely used in US vaccines, its inclusion on the Advisory Committee on Immunization Practices' agenda alarmed experts, who say the move has effectively embedded anti-vaccine talking points into national policy.

Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 ACIP members earlier this month, accusing them of conflicts of interest.

Across three votes, his new handpicked panelists recommended that thimerosal be removed from influenza vaccines for children, pregnant women and finally all adults.

Cody Meissner, a professor of pediatrics at Dartmouth University and the lone voice of dissent, said: "The risk from influenza is so much greater than the nonexistent risk as far as we know from thimerosal," adding that he was worried about the decision's global impact.

Although 96 percent of US flu vaccines in the 2024-2025 season did not contain thimerosal, the preservative remains important globally, particularly in multidose vials that must be punctured repeatedly, raising the risk of contamination.

Thimerosal contains an artificial form of mercury called ethylmercury that is cleared from the body far more quickly than the form of the substance found in nature.

US manufacturers voluntarily removed it from most pediatric vaccines in 2001.

- 'Platform for anti-vaccine talking points' -

"The fact that it's being brought up again -- something that's already been adjudicated -- shows how the ACIP is becoming a platform for anti-vaccine talking points to come back to life long after most of us thought they'd been put to rest," Amesh Adalja, an infectious disease specialist at Johns Hopkins University, told AFP.

Ahead of the vote, Lyn Redwood, a nurse and former leader of the anti-vaccine group Children's Health Defense, which Kennedy once chaired, was invited to present arguments against thimerosal.

A previous version of her slideshow, which was posted online before the meeting, was removed without explanation after it was found to contain a fabricated citation, likely the result of an AI hallucination.

The Centers for Disease Control and Prevention had prepared a rebuttal to Redwood's presentation, but it was mysteriously removed from the meeting website.

Robert Malone, a new panel member known for spreading misinformation during the Covid-19 pandemic, including promoting the antiparastic drug ivermectin to treat the virus, later said the CDC document had not been approved by the Office of the Secretary.

Earlier in the meeting, the same panel voted to recommend a new antibody treatment against RSV, a common respiratory illness and the leading cause of infant hospitalization in the United States.

Clesrovimab, recently approved by the Food and Drug Administration, is administered as a single shot to newborns and young babies entering their first respiratory syncytial virus season.

Marketed as Enflonsia by Merck, it was shown in clinical trials to significantly reduce RSV infections and hospitalizations among infants.

P.McDonald--TFWP